Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.40 |
| ▸ | PGR | P06401 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.33 |
| ▸ | STK10 | O94804 | 2/20 | 0.32 |
| ▸ | SLK | Q9H2G2 | 2/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.31 |
| ▸ | CLK1 | P49759 | 1/20 | 0.31 |
| ▸ | CLK2 | P49760 | 1/20 | 0.31 |
| ▸ | SRPK2 | P78362 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21239499 | 0.96 | PDK2 (0.38) | PDK2PGRALDH1A1ATMGABRA1 | |
| SCHEMBL3222953 | 0.89 | PDK2 (0.44) | PDK2PGRALDH1A1ATMGABRA1 | |
| SCHEMBL22597479 | 0.84 | PDK2 (0.42) | PDK2PGRALDH1A1ATMGABRA1 | |
| SCHEMBL22113244 | 0.81 | — | — | |
| SCHEMBL25129017 | 0.80 | PDK2 (0.39) | PDK2PGRALDH1A1ATMGABRA1 | |
| SCHEMBL22597474 | 0.80 | CHEK1 (0.31) | CHEK1 | |
| SCHEMBL22597476 | 0.80 | PLA2G2A (0.34) | PGRALDH1A1 | |
| SCHEMBL25129196 | 0.80 | PDK2 (0.32) | PDK2PGR | |
| SCHEMBL22916804 | 0.80 | PDK2 (0.38) | PDK2PGRALDH1A1ATMGABRA1 | |
| SCHEMBL22113229 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345816-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230345816-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230242465-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
| US-11618722-B2 | Compound, composition, organic electroluminescent element, and electronic appliance | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-04 | — | — | US | disclosed |
| US-20230047477-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20230042023-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| US-11552252-B1 | — | — | 2023-01-10 | — | — | US | disclosed |
| US-20220285625-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-09-08 | — | — | US | disclosed |
| WO-2021107030-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2021-06-03 | — | — | WO | disclosed |
| US-20210028365-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242465-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | EP300, RPS19, RER1 | PDK2 2873/4885PGR 2422/4885ALDH1A1 2901/4885 |
| US-11618722-B2 | Compound, composition, organic electroluminescent element, and electronic appliance | FGF23, SUZ12, RPL24 | PDK2 4233/4885PGR 3984/4885ALDH1A1 3606/4885 |
| US-20230345816-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | LEF1, L1CAM, YBX1 | PDK2 1014/4885PGR 1822/4885ALDH1A1 2247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.